A Case Report of Clinical Remission of Multiple Myeloma with Yoga Prana Vidya Healing as complementary therapy

super brain

A Case Report of Clinical Remission of Multiple Myeloma with Yoga Prana Vidya Healing as complementary therapy

Publication: Journal of Carcinogenesis

 

Article link: https://carcinogenesis.com/index.php/JOC/article/view/1982/2237

 

Authors:

 

Anvita Bhatt

 

YPV Senior Trainer, and YPV Level 6 and Certified Healer, Raipur, Chhattisgarh, India

 

Mohini Yagnik

 

Associate Certified YPV Healer, Ujjain, MP, India

 

Venkata Satyanarayana Nanduri

 

Consultant, Research & Publications, YPV Ashram, Sri Ramana Trust, Thally-635118, Tamil Nadu, India

Abstract :

Background: Multiple myeloma is a plasma cell malignancy characterized by clonal proliferation, paraprotein secretion, and end-organ damage, where relapse and immune suppression remain challenging despite chemotherapy and immunotherapy.

Objective: To evaluate the synergistic clinical outcomes and efficacy of combining standard chemotherapy with Yoga Prana Vidya (YPV) healing as a safe, cost-effective complementary therapy for multiple myeloma.

Methodology:


Patient Profile: A 64-year-old male physician diagnosed with IgG kappa myeloma in December 2025 presenting with shoulder pain, back pain, breathlessness, and initial lab abnormalities including a free kappa light chain of 642.4 mg/L and kappa/lambda ratio of 28.67.

Intervention: The patient received oral and injectable chemotherapy for four months alongside daily YPV healing sessions (30 minutes morning and evening) administered for four months.

 

YPV Protocols Used: Healer Development Program Level 1 (HDPL1) protocols and YPV Level 6 healing protocols.

Results: Serial biomarkers showed a dramatic decline in free kappa light chains from 642.4 to 4.6 mg/L, normalization of the kappa/lambda ratio from 28.67 to 0.75, and an LDH reduction from 378 to 203 U/L.
Clearance of monoclonal protein and clinical remission were confirmed by April 2026, allowing the patient to resume professional duties by the third month, though persistent hypogammaglobulinemia required monitoring.

Conclusion: YPV healing serves as a safe and cost-effective complementary therapy that enhances resilience and recovery in myeloma management, warranting further controlled studies.

Leave Feedback